A few clinics in the United States are starting to sequence the
full genomes of patients
whose diseases can't be identified by the standard battery of genetic tests, or
whose diseases resist conventional treatments.
One of the ten emerging technologies selected was the Human Cell Atlas, which aims to integrate research exploring all the «omes»: the
genome (the
full set of genes), the transcriptome (the RNA made from all genes), the proteome (the proteins), the metabolome (small molecules, such as sugars, fatty acids and amino acids, involved or generated by cellular processes), and the fluxome (metabolic reactions
whose rates can vary under different conditions).